Skip to Main Content

Author Details

Andrea Viale
The University of Texas MD Anderson Cancer Center
2001
45
23
PMIDPaper TitleJournal TitlePublished Year
36865225Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma.bioRxiv2023
37790498KRAS inhibition activates an actionable CD24 'don't eat me' signal in pancreas cancer.bioRxiv2023
37786705Evolutionary fingerprints of EMT in pancreatic cancers.bioRxiv2023
37186844SMARCB1 regulates the hypoxic stress response in sickle cell trait.Proc Natl Acad Sci U S A2023
37069167Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis.Nat Commun2023
36411320Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells.Nat Cancer2022
35697807Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.Nat Biotechnol2022
33158812Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress.Cancer Res2021
33745946Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer.Gastroenterology2021
34529467Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.Science2021
34039636Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma.Cancer Discov2021
34062049miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC.EMBO Mol Med2021
34330913PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.Nat Commun2021
32977289Leukotrienes, a potential target for Covid-19.Prostaglandins Leukot Essent Fatty Acids2020
30753823p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.Cancer Cell2019
31623133The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?Cancers (Basel)2019
30918400Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.Nature2019
30726735Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors.Cell Rep2019
30602939Analytical mechanics of asteroid disassembly using the Orbital Siphon effect.Proc Math Phys Eng Sci2018
28178232Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.Nature2017
28099419Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer.Nature2017
26799652Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).Autophagy2016
27557537Metabolic Features of Cancer Treatment Resistance.Recent Results Cancer Res2016
27320920In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.Cell Rep2016
25736685Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer.Cancer Res2015
26374463Tumors and mitochondrial respiration: a neglected connection.Cancer Res2015
26445511Sugar? No Thank You, Just a Deep Breath of Oxygen for Cancer Stem Cells.Cell Metab2015
25965571Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome.Cancer Cell2015
24954535Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.Cell2014
25227008Quest for an open MRI scanner.Biomed Mater Eng2014
25119024Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.Nature2014
23584564NPMc+ and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model.Leukemia2013
24091730A non-redundant function of cyclin E1 in hematopoietic stem cells.Cell Cycle2013
23417300DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions.Proc Natl Acad Sci U S A2013
22541435Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.Cell2012
23226099Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential.Neoplasia2012
21331069The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha.Leukemia2011
19122635Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells.Nature2009
20049708Awaking stem cells from dormancy: growing old and fighting cancer.EMBO Mol Med2009
19713969Does treatment with olmesartan improve arterial stenoses due to fibromuscular dysplasia?Hypertens Res2009
16418776Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease.J Bone Miner Res2006
15619634Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway.Nat Med2005
15208264Vasculogenic potential of long term repopulating cord blood progenitors.FASEB J2004
12453876Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient.Blood2002
11313686Detection of breast cancer cell contamination in leukapheresis product by real-time quantitative polymerase chain reaction.Bone Marrow Transplant2001
  • 1 - 45 of 45

Recommended Authors

University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 3
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year 2012
Number of shared co-authors 13
University of California san francisco
Career Start Year 2011
Number of shared co-authors 0
2Ontario Institute for Cancer Research
Career Start Year 2009
Number of shared co-authors 2
Harvard Medical School
Career Start Year 2009
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 6
Oncode Institute
Career Start Year 2006
Number of shared co-authors 4
H. Lee. Moffitt Cancer Center
Career Start Year 2005
Number of shared co-authors 4
Duke University
Career Start Year 2005
Number of shared co-authors 5
University of Southern California
Career Start Year 2004
Number of shared co-authors 1
University of California los angeles
Career Start Year 2003
Number of shared co-authors 1
Cancer Research UK Manchester Institute, University of Manchester
Career Start Year 2003
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 11
University of California san francisco
Career Start Year 1999
Number of shared co-authors 5
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1998
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1997
Number of shared co-authors 2
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 1992
Number of shared co-authors 10
University of Colorado Anschutz Medical Campus
Career Start Year 1991
Number of shared co-authors 1
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 0
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Career Start Year 1989
Number of shared co-authors 2
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 4
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 2
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 12
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 1
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 5
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 6
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1975
Number of shared co-authors 2
National Cancer Institute
Career Start Year 1945
Number of shared co-authors 0

Collaborators

Co-authored papers 15
The University of Texas MD Anderson Cancer Center
Co-authored papers 10
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Istituto Europeo di Oncologia IRCCS
Co-authored papers 6
Co-authored papers 5
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 2
Francis Crick Institute
Co-authored papers 2
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 2
University of Oxford
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
MD Anderson Cancer Center
Co-authored papers 2
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Queen's University Belfast
Co-authored papers 1
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Co-authored papers 1
Walter and Eliza Hall Institute of Medical Research
Co-authored papers 1
University of California san francisco
Co-authored papers 1